Abstract:OBJECTIVE:To investigate the clinical characteristics and therapeutic effect in the early stage of patients with Severe Acute Respiratory Syndrome (SARS).METHODS:A total of 45 clinical diagnosed SARS patients were enrolled in the study.RESULTS:43 (95.6%) of all 45 patients had exposure to SARS patients and the average incubation time was (7.3 +/- 4.7) days (range 2 to 20 days). The clinical features including fatigue (60%), dry cough (68.9%), dyspnea (53.3%), joint pain (26.7%) and diarrhea (26.7%). The laboratory test show that 33% patients with leukopenia and thrombocytopenia, 53.3% with elevated serum aminotransferase and 26.6% with increased creatinine kinase levels. The occurrence of abnormal chest radiographs was (4.2 +/- 2.9) days from the onset, and CT scanning was better than X-ray in the early diagnosis. The average time for the progression and improvement of the chest radiographs were (9.3 +/- 4.1) and (14.5 +/- 5.0) days, respectively. The administration of corticosteroids was started (4.8 +/- 3.5) days from the onset and the maximal dosage using of steroids was (8.4 +/- 3.9) days. There was a significant difference in the dosage of steroid between severe and mild patients [(610.6 +/- 212.4) mg/day vs (268.1 +/- 202.5) mg/day, P < 0.001)]. The IgG antibody was detected in 22 out of 34 (64.7%) patients and the average time for the occurrence of antibody was (18.2 +/- 6.4) days (range 9-27 days).CONCLUSION:Exposure to the SARS patients happened in most patients. The most common clinical features were fever and fatigue. The most common laboratory abnormalities were leukopenia and thrombocytopenia. Serum antibody was not detected until on the 9th day of the course of illness; CT is a more sensitive method for detection of the abnormal chest radiographs than regular X-ray test. The early usage of cortiscosteroids was an efficient method for the treatment, and the dosage of steroids should be individualized.

Follow up analysis of laboratory results in 77 medical staff suffered from severe acute respiratory syndrome

Dynamic Changes of Viral Load and Antibodies Level in the Patients of Severe Acute Respiratory Syndrome

[Prospective Clinical Study on Serum Immunity in IgG-antibodies Positive Patients Convalescent from Severe Acute Respiratory Syndrome].

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

Analysis of pulmonary function and CT appearances in 76 medical staffs with severe acute respiratory syndrome during convalescence

Analysis on Diagnosis and Treatment with Integrated Traditional Chinese and Western Medicine in 20 Severe Acute Respiratory Syndrome Patients Infected in Hospital

Dynamic Changes in IgG and IgM Antibodies As Clinical Indicators During Recovery Stage in Patients with Severe Acute Respiratory Syndrome

[Retrospective Analysis on Clinical Features of 35 Patients with Severe Acute Respiratory Syndrome].

Measurement of the T Lymphocyte Subsets and the Th1/Th2 Cytokines in Patients with Severe Acute Respiratory Syndrome

[Prospective 2-Year Clinical Study of Patients with Positive IgG-antibodies after Recovering from Severe Acute Respiratory Syndrome].

Dynamics of Peripheral Blood Lymphocytes and Their Subpopulations in Patients with Severe Acute Respiratory Syndrome

Clinical Analysis of 120 Cases of Patients with Severe Acute Respiratory Syndrome

Clinical analysis of 56 patiens with critical severe acute respiratory syndrome in Beijing area

Death and recovery in SARS:120 cases analysis

Analysis of Severe Acute Respiratory Syndrome in Beijing

[The Clinical Characteristics and Outcome of 45 Early Stage Patients with SARS].

[Immunological Characteristics of 1291 Cases of Severe Acute Respiratory Syndrome in Beijing].

[Dynamics of Peripheral Blood B Lymphocytes and Natural Killer Cells in Patients with Severe Acute Respiratory Syndrome].

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Clinical Analysis of 197 Patients with Critical Severe Acute Respiratory Syndrome in Beijing Areas

[Primary Investigation on the Changing Mode of Plasma Specific IgG Antibody in SARS Patients and Their Physicians and Nurses].